Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Nov 24;15(11):e0236208. doi: 10.1371/journal.pone.0236208

3 versus 7 Tesla magnetic resonance imaging for parcellations of subcortical brain structures in clinical settings

Bethany R Isaacs 1,2, Martijn J Mulder 1,3, Josephine M Groot 1, Nikita van Berendonk 1, Nicky Lute 1,4, Pierre-Louis Bazin 1,5, Birte U Forstmann 1,#, Anneke Alkemade 1,*,#
Editor: Xi Chen6
PMCID: PMC7685480  PMID: 33232325

Abstract

7 Tesla (7T) magnetic resonance imaging holds great promise for improved visualization of the human brain for clinical purposes. To assess whether 7T is superior regarding localization procedures of small brain structures, we compared manual parcellations of the red nucleus, subthalamic nucleus, substantia nigra, globus pallidus interna and externa. These parcellations were created on a commonly used clinical anisotropic clinical 3T with an optimized isotropic (o)3T and standard 7T scan. The clinical 3T MRI scans did not allow delineation of an anatomically plausible structure due to its limited spatial resolution. o3T and 7T parcellations were directly compared. We found that 7T outperformed the o3T MRI as reflected by higher Dice scores, which were used as a measurement of interrater agreement for manual parcellations on quantitative susceptibility maps. This increase in agreement was associated with higher contrast to noise ratios for smaller structures, but not for the larger globus pallidus segments. Additionally, control-analyses were performed to account for potential biases in manual parcellations by assessing semi-automatic parcellations. These results showed a higher consistency for structure volumes for 7T compared to optimized 3T which illustrates the importance of the use of isotropic voxels for 3D visualization of the surgical target area. Together these results indicate that 7T outperforms c3T as well as o3T given the constraints of a clinical setting.

Introduction

The availability of 7 Tesla (T) Magnetic Resonance Imaging (MRI) scanners has rapidly increased in recent years [13]. The theoretical benefits of anatomical 7T MRI over lower field strengths can be attributed to the increased spatial resolution, contrast- and signal-to-noise ratios (CNR and SNR, respectively), which collectively result in higher quality imaging within feasible time frames [4, 5]. Improved visibility of pathological alterations on 7T has been reported in the literature for brain tumors [6], epilepsy [7], multiple sclerosis [8], stroke [9], and neurodegenerative diseases [10]. However, to what extent increased visibility afforded by 7T has the potential to improve clinical outcomes regarding invasive neuro interventions remains unknown.

A promising clinical application of 7T MRI is the target visualization of structures for deep brain stimulation (DBS) surgery [1, 11]. DBS procedures target structures within the subcortex, which is comprised of a large number of small, iron and calcium-rich nuclei that are located in close proximity to one another [2]. The main DBS targets for PD and dystonic disorders are the globus pallidus interna (GPi) and subthalamic nucleus (STN) [1215]. Identification of the STN benefits from visualization of the border of the SN, which has also been targeted for epilepsy [16]. Also the parcellation of the GPi benefits from visualizing the boundary with the external segment of the GP (GPe), the stimulation of which has been shown to modulate functional connectivity in Huntington’s disease patients [17]. Additionally, the red nucleus (RN) is often used as a landmark for identification and orientation of the surrounding nuclei [18].

Alterations in biometals such as iron in human tissue are commonly observed in pathological processes, for instance, the occurrence of dopaminergic neurodegeneration of the substantia nigra (SN) in Parkinson’s disease (PD). Such changes in the chemical composition can cause disease specific structural alterations in shape, volume and location [1921]. Moreover, the neurophysical properties of both physiological and aberrant accumulation of biometals can be exploited to increase the visibility of structural boundaries with both ultra-high field (UHF) MRI and tailored post-processing techniques, such as quantitative susceptibility mapping (QSM) [2225].

Conventional MRI can fail to capture the detailed local neuroanatomy due a weaker field strength, resulting in reduced spatial resolution, signal and contrast. These limitations can be directly translated into a clinical setting with regards to the accuracy of MRI based targeting protocols for DBS implantations. DBS of the STN has been related to a number of psychiatric, cognitive, and emotional disturbances [26]. Moreover, a fraction of patients will fail to respond to stimulation and or maintain their parkinsonian symptoms, and may require the removal or reimplantation of their DBS leads [26, 27]. These failures to appropriately respond to neurointervention can partially be attributed to suboptimal placement of the DBS lead as a consequence of both inaccurate visualization of the target and reliance on landmark identification [28]. Additionally, DBS surgeries commonly incorporate intra-operative micro electrode recordings and behavioral testing in awake patients to confirm optimal lead placement [2931]. This is a time-consuming procedure and distressing for the patient. The higher spatial accuracy that 7T MRI offers could contribute to more accurate surgical targeting and clinical efficacy. Additionally, it can reduce the length of the surgery and the requirement for reimplantation, while ultimately contributing to the abolishment of the need for awake testing during surgery and dramatically improving patient comfort [1, 32].

Clinical MRI often includes parallel imaging (PI) techniques to reduce acquisition time which is associated with an SNR penalty. This is warranted for both practical reasons, to improve image contrast, as well as clinical reasons, as patients with movement disorders cannot be scanned for extended periods of time. PI reconstructions result in spatially varying noise amplification, which is reflected in the g-factor. However, PI can result in both g-factor penalties and longitudinal magnetization saturation, which can produce anatomically inaccurate and distorted images [2, 33]. In clinical practice, anisotropic voxel sizes are commonly employed in order to maintain a higher SNR in-plane.

In our current studies, we investigate the potential of 7T for improved targeting with a quantitative comparison of 3T with 7T MRI scans. We acquired two sets of 3T data; one representative of the resolution of clinical 3T (c3T) MRI typically used for DBS targeting, as well as an optimized set of 3T (o3T). Additionally, we obtained a set of 7T data from the same participants. We would like to clarify that we could not run the same optimized protocol at 3T and 7T. Running the 7T protocol at 3T would result in an unacceptably increased scan time at 3T which would preclude clinical implementation. Furthermore, the increase in specific-absorption-rates (SAR) escalating magnetization would result in local tissue heating, thereby posing a severe health risk to those scanned. Direct quantitative comparisons were drawn from both manual and semi-automated parcellations the GPe, GPi, RN, SN, and STN. Given the iron rich nature of these deep brain structures, and our previous studies indicating that for such structures QSM outperforms T2*-weighted images we used QSM contrasts for parcellations [34]. Additionally, a semi-automated parcellation approach was employed to parcellate the GP, RN, SN and STN, in order to identify potential biases occurring with manual parcellations and whether accuracy increases with field strength.

Methods

Participants

10 healthy participants (male = 2, female = 8, mean age = 25.9 y, S.D age = 5.8 y), healthy as assessed by self-reports, were scanned at the Spinoza Centre for Neuroimaging in Amsterdam, The Netherlands, on a Philips 7T and 3T Achieva MRI system, with a 32-channel head array coil. The research was approved in writing by the LAB Ethics Review Board of the Faculty of Social and Behavioral Sciences, the local Ethical Committee of the Department of Psychology at the University of Amsterdam (ERB number 2016-DP-6897). All participants provided written informed consent prior to the scanning, and structural 7T MRI data was included in the Amsterdam ultra-high field adult lifespan database (AHEAD) [35].

Data acquisition

c3 Tesla

Whole-brain T1-weighted images obtained with a 3D Turbo/Fast Field Echo (TFE) sequence with 1mm isotropic voxel sizes, field of view (FOV) = 240 x 188, 220 slices, echo time (TE) = 3.7 ms, repetition time (TR) = 8.2 ms, TFE factor = 142, TFE shots = 118, SENSEPA = 2.5, acquisition time (TA) = 04:42 min, obtained in the transverse plane. Whole-brain T2-weighted images obtained with a Turbo/Fast Spin Echo sequence (TSE) with 0.45 x 0.45 x 2mm voxel sizes, FOV = 230 x 182, 48 slices, TE = 80 ms. TR = 3000 ms, TSE factor = 15, TSE shots = 150, TA = 06:12 min, obtained in the transverse plane. Total acquisition time was 10:54 min.

o3 Tesla

Whole-brain T1-weighted images were obtained with a 3D Fast Field Echo (FFE) sequence with 1mm isotropic voxel sizes, FOV = 240 x 188, 220 slices, TE = 3.7 ms, TR = 8.2 ms, TFE factor = 142, TFE shots = 293, TA = 11:38 min in the transverse plane (no acceleration factor). Whole brain T2-weighted images were acquired with 3D Fast Field Echo (FFE) sequence with voxel sizes 1mm isotropic, TE1, 2, 3, 4, 5 = [4.1, 9.8, 13.85, 19.55, 23.60 ms], TR = 46 ms, echo spacing (ES) = 9.75 ms, FA = 20, FOV = 240 x 188, 140 slices, SENSEPA = 2, TA = 10:08 min. The main difference between the clinical and optimized 3T scans is the voxel size. Two separate scans were collected with o3T, with a total acquisition time of 21:46 min. We would like to note that we were unable to match the o3T spatial resolution with that of the 7T due to specific absorption rate (SAR) limitations.

7 Tesla

For 7T, one scan incorporating both T1 and T2* contrasts was obtained using a MP2RAGEME (magnetization-prepared rapid gradient echo multi-echo) sequence [36]. The MP2RAGEME is an extension of the MP2RAGE sequence by [37] and consists of two rapid gradient echo (GRE1,2) images that are acquired in sagittal plane after a 180° degrees inversion pulse and excitation pulses with inversion times TI1,2 = [670 ms, 3675.4 ms]. A multi-echo readout was added to the second inversion at four echo times (TE1 = 3ms, TE2,1–4 = 3, 11.5, 19, 28.5 ms). Other scan parameters include flip angles FA1,2 = [4°, 4°]; TRGRE1,2 = [6.2 ms, 31 ms]; bandwidth = 404.9 MHz; TRMP2RAGE = 6778ms; acceleration factor SENSEPA = 2; FOV = 205 x 205 x 164 mm; acquired voxel size = 0.70 x 0.7 x 0.7 mm; acquisition matrix was 292 x 290; reconstructed voxel size = 0.64 x 0.64 x 0.7 mm; Turbo/Fast factor (TFE) = 150 resulting in 176 shots; Total acquisition time = 19:53 min.

Image calculations

T2* maps for o3T and 7T MRI scans were created by least-squares fitting of the exponential signal decay over the multi-echo images of the second inversion. 7T T1-weighted images were generated by complex ratio of the product of first and second inversion over the sum of their square [37]. A quantitative T1 map was also reconstructed from this T1-weighted image via a look-up table procedure [37]. For QSM, the 3T data underwent more extensive clipping at the frontal and sinus regions as compared to the 7T MRI data. This was required since the algorithm is sensitive to non-local artefacts, which are more prominent in these regions on o3T MRI scans. For QSM, phase maps were pre-processed using iHARPERELLA (integrated phase unwrapping and background phase removal using the Laplacian) of which the QSM images were computed using LSQR [38, 39]. Scans were reoriented and skull information was removed as described previously [40]. The c3T MRI sequence did not allow the calculation of quantitative T2* maps or QSM images.

Parcellation methods

Manual parcellation

Inspection of the c3T scans revealed that despite the high in-plane resolution, which allowed the identification of the structures of interest in the axial plane, we were unable to create a biologically plausible 3-dimensional reconstruction of the structures of interest due to the anisotropic nature of the voxel sizes. We therefore decided not to pursue further analyses of the c3T MRI scans. Multi-echo data was not acquired, and therefore it was not possible to reconstruct QSM images for parcellations.

For o3T and 7T images, manual parcellations were performed in individual space using the QSM images for the GPe/i, RN, SN, and STN by two independent trained researchers. Given the level of familiarity of these raters with MRI data, we concluded that blinding for the scan sequence was impossible. T1-maps and/or T1-weighted images were used for additional anatomical orientation and identification of landmarks such as the ventricles, pons and corpus callosum. T2*-maps were also used where appropriate. See S1 File for the approach used for manual parcellations. Raters were blind to each other’s parcellations, and inter-rater agreement was determined by the Dice correlation coefficient (see statistical methods).

Semi-automated parcellation: Multimodal Image Segmentation Tool (MIST). Semi-automated parcellation was performed for the combined GPe/i, RN, SN and STN with FSL’s Multimodal Image Segmentation Tool (MIST) [41, 42]. QSM-maps and T1-weighted images were used as input for MIST. MIST output parcellations were compared across field strength (o3T vs 7T), as well as across parcellation method (manual vs. semi-automated) in order to assess for potential biases in manual parcellations such as order or practice effects.

The o3T brain extracted T1-weighted and QSM maps were co-registered via a multi-step process, where first whole brain T2*-maps were registered to the corresponding T1-weighted images using FLIRT (as implemented in FSL version 6.0.1) with 6 degrees of freedom, nearest neighbor interpolation and mutual information cost function. This transformation was then applied to the QSM-maps, extrapolated form the fifth echo of the T2* sequence, also with 6 degrees of freedom, mutual information cost function and instead a sinc interpolation. The same transforms were applied to the manual parcellations to allow for direct comparisons with MIST outputs. All registrations were visually inspected for misalignments by comparing the following landmarks: ventricles, pons, and corpus callosum.

The 7T MP2RAGEME sequence allowed the calculation of all contrasts from a single sequence and thus in the same space, not requiring any registration steps. The MP2RAGE was used as the whole-brain anatomical reference image and the fourth echo of the second inversion was used for the T2* image. Resampling was achieved with Nibabel (version 2.3), with second order spline interpolation, and constant mode parameter. Where appropriate, the header information was copied from the fourth echo of the second inversion to the MP2RAGE. Images were resampled as MIST only handles (near) isotropic voxel sizes. MIST was unable to perform parcellations in 0.7 mm isotropic voxels, which we attributed to the limited information provided by the prior derived from MNI-space for these small voxels. Images were therefore resampled to 0.8 mm which resolved the problem.

Dice coefficients

Dice coefficients were assessed to determine interrater reliability [43]. Dice scores were compared between o3T and 7T images to test the directed hypothesis that 7T images result in higher interrater agreement as compared to o3T images. The Dice coefficient was calculated as follows:

Dice=2×m1m2m1+m2

Where |mi| is the size of mask i and |m1m2| is the size of the conjunct mask of mask 1 and 2. A conjunct mask of a set of masks M only includes voxels included by both raters [43].

Volume calculations

For manual parcellations, all volume calculations were performed using the conjunct volume of the individual raters, as described previously. Calculations for manual Dice factors were calculated in the space in which the parcellations were performed [34, 44]. Masks from the MIST output were compared with manually parcellated conjunction masks resampled to 0.8mm for the 7T data, and the masks that were registered from T2* to T1 for the o3T MRI data.

Anatomical distance

The anatomical distance between the centers of mass of the individual structures in the left and right hemisphere was assessed, providing a measure for changes in the perceived location of the individual structures across field strengths. We expected that altered visibility of specific anatomical borders would be reflected in a bilateral shift in the center of mass and as a result an altered anatomical distance.

Distances were calculated as follows:

Distance(l,r)=i=1n

l and r correspond to the left and right hemisphere. The square root of the sum is obtained by adding the power of the left x, y and z coordinates of the center of mass of the individual structures l and r [45].

Contrast to noise ratios

Contrast-to-noise ratios (CNRs) of the QSM images were calculated to assess differences in visibility of the anatomical structure under investigation. Intensities of non-zero voxels were extracted using the segmentation_statistics implemented in Nighres [46]. The CNR was calculated as follows:

CNR=SISOσO

SI is the signal inside the mask, represented by the mean value of all the voxels in the conjunct mask. SO is the signal outside the mask, calculated as the mean value of all voxels that directly border the outside of the disjunct mask (all voxels scored inside the mask of a single rater). σ0 is the standard deviation of the set of QSM intensities in these voxels. This approach was adopted to ensure that voxels outside the mask were not part of the separate individual masks.

Statistical methods

All statistical analyses were conducted within a Bayesian framework (Table 1) using the BayesFactor toolbox [47] in R [48], interpreted in light of the assumptions proposed by [49] and adapted by [50]. Bayesian approaches draw their distribution from the observed data, rather than requiring a Gaussian distribution, which can be difficult to meet in both small and or clinical datasets when using a frequentist perspective. Bayesian statistics sample from the data itself, the priors for each group are calculated independently, in which smaller groups will receive greater uncertainty compared to a larger group for comparison, with no trade off with statistical power [51]. Therefore, a limited number of subjects should not negatively impact our results [52, 53]. Each test is performed independently of the others so we assume multiple comparisons are not a confounder in the present study [5456]. We incorporated a within subjects’ approach, and for all analyses data was collapsed across hemisphere.

Table 1. Bayes factor interpretation.

Bayes Factor Interpretation
BF10 >100 Decisive evidence
Evidence for H1
30–100 Very strong evidence
10–30 Strong evidence
3–10 Substantial evidence
1–3 Anecdotal evidence
1 No evidence
BF01 1–0.33 Anecdotal evidence
Evidence for H0
0.33–0.10 Substantial evidence
0.10–0.03 Strong evidence
0.03–0.01 Very strong evidence
<0.01 Decisive evidence

H1 = experimental hypothesis, and H0 = null hypothesis.

Manual o3T v 7T

For manual parcellations, we hypothesized that Dice scores and CNRs are higher for 7T compared to o3T MRI scans, as assessed with one-tailed paired samples t-tests per structure. For each one-tailed test, two models were obtained. The first model (M1) tested for a positive effect in support of our hypotheses, and a second model (M2), tested for a negative effect in which 7T is either no different or is outperformed by the o3T MRI data. The preferred model, which was the model for which strongest evidence was present, was then reported along with the model comparisons.

We had no hypotheses on the direction of potential changes in volumes or Anatomical distances across field strengths, and therefore conducted two-tailed paired samples t-tests. These analyses provided a single model testing for a difference either way, compared to the null hypothesis. Where appropriate, we calculated the reciprocal to determine the evidence supporting the null-hypothesis.

Manual v semi-automated

Similarly, when assessing manual and semi-automated parcellations within field strength (manual o3T v MIST 3T and manual 7T v MIST 7T), two-tailed paired samples t-tests were conducted for CNRs, volumes, and Anatomical distances, which we did not expect to differ.

The Dice score for the MIST output parcellations is comprised of a conjunction mask including only the voxels selected by both the MIST parcellation and the resampled manual conjunction mask. Therefore, Dice scores were not directly tested across parcellation methods.

Semi-automated o3T v 7T

o3T and 7T MIST parcellation Dice scores and CNRs were compared with a one-tailed paired samples t-test, under the assumption that both Dice scores and CNRs would be higher for 7T than for o3T, indicating that 7T is subject to fewer biases than o3T. Volumes and Anatomical distances were again assessed with two-tailed paired samples t-tests.

Data sharing and accessibility statement

All anonymized data and analysis scripts are available from https://osf.io/4nrku/, under the terms of the Creative Commons Attribution License and complies with the rules of the General Data Protection Regulation (EU) 2016/679.

Results

The MR contrasts are illustrated in Fig 1. QSM contrasts obtained from o3T and 7T sequences allowed for manual parcellation of the brain structures under investigation, resulting in biologically plausible 3D reconstructions (see Figs 2 and 3). As previously mentioned, the c3T images provided excellent in-plane resolution, though did not reasonably allow for anatomically accurate reconstructions due to the anisotropic voxel sizes. Therefore, no formal analyses were pursued for the clinical scans. All results have been averaged across hemisphere, and presented with a margin of error of <0.1%. See Table 2 for the results of the manual parcellations, and Tables 3 and 4 and Fig 4 for MIST parcellations.

Fig 1. Contrasts.

Fig 1

A single subject's 7T (T1-weighted, T2* map and QSM images), optimized 3T (o3T) (T1-weighted, T2* map and QSM images) and clinical 3T (c3T) (T1- and T2*- weighted) in the coronal and axial planes. Brightness and contrast levels were chosen to best visualize the basal ganglia.

Fig 2. Voxel sizes.

Fig 2

Example of a single subjects clinical 3T (c3T) T2 weighted, optimized 3T (o3T) and 7T T2* maps in the coronal, sagittal and axial planes. Voxel sizes are indicated on the right side of the figure. The RN, SN and STN are highlighted to exemplify the difficulty in identification of the nuclei in the coronal and sagittal planes for the c3T compared to the o3T and 7T due to the anisotropic voxel sizes, making 3D parcellations impossible. T2 weighted images and T2* maps are presented as they show the iron rich RN, SN and STN as hypointense structures. This was done since the c3T scan did not allow for QSM calculations, which would result in a hyperintense contrast of these brain nuclei.

Fig 3. QSM of manual STN parcellations.

Fig 3

Example of a single subject parcellation of the STN on QSM images. Unlabelled and parcellated images reflect the same anatomical level in native space.

Table 2. Comparison of manual parcellations across optimized 3T and 7T MRI.

Structure Dice scores Conjunct Volumes Anatomical Distance QSM CNRs
One-tailed Two-tailed Two-tailed One-tailed
o3T 7T BF o3T 7T BF o3T 7T BF o3T 7T BF
GPe 0.77 (0.04) 0.81 (0.05) M1 BF10 = 4.11 (Mc BF10 = 34.26) 1047 (127.46) 999.52 (136.57) BF01 = 0.58 37.35 (1.67) 36.72 (1.22) BF01 = 0.86 1.22 (0.16) 1.09 (0.14) M2 BF10 = 5.43 (Mc BF10 = 46.65)
GPi 0.71 (0.06) 0.76 (0.05) M1 BF10 = 4.22 (Mc BF10 = 35.13) 420.25 (85.71) 415.09 (95.59) BF01 = 0.31 31.35 (2.00) 31.95 (1.40) BF01 = 0.89 0.81 (0.16) 0.75 (0.15) M2 BF01 = 0.66 (Mc BF10 = 3.62)
RN 0.80 (0.06) 0.85 (0.03) M1 BF10 = 7.20 (Mc BF10 = 63.73) 233.40 (45.44) 227.44 (32.59) BF01 = 0.47 8.73 (0.41) 8.71 (0.43) BF01 = 0.32 1.92 (0.51) 2.05 (0.42) M1 BF10 = 1.64 (Mc BF10 = 11.76)
SN 0.78 (0.07) 0.81 (0.03) M1 BF10 = 1.06 (Mc BF10 = 6.89 434.45 (75.49) 401.39 (91.94) BF01 = 0.35 16.49 (0.83) 16.45 (0.48) BF01 = 0.31 1.62 (0.17) 1.78 (0.32) M1 BF10 = 1.20 (Mc BF10 = 7.87)
STN 0.69 (0.06) 0.74 (0.06) M1 BF10 = 1.85 (Mc BF10 = 13.59) 88.90 (15.12) 87.35 (23.20) BF01 = 0.51 17.93 (1.34) 17.71 (1.47) BF01 = 0.34 1.04 (0.26) 1.33 (0.32) M1 BF10 = 61.75 (Mc BF10 = 629.61)

Dice scores, conjunct volumes, Anatomical distances, and QSM CNRs are averaged across hemisphere and presented as mean values and standard deviations for o3T and 7T MRI contrasts. BF10 indicates evidence for the alternative, and BF01 refers to evidence for the null hypothesis. Dice scores and QSM CNRs were compared using a Bayesian one-tailed paired samples t-test, where BF10 assumes that in both cases 7T is higher than o3T (model 1 (M1)), and BF01 assumes either no difference or a decrease in 7T compared to o3T (model 2 (M2)). For one-tailed paired samples t-tests, only the BF for the winning model is noted, and the likelihood ratio is calculated between the winning and losing models and is noted by ‘Mc’ (standing for model comparisons). Conjunct volumes and Anatomical distances were compared between 3T and 7T with two-tailed paired-samples t-tests. o3T = optimized 3T, QSM = quantitative susceptibility mapping, CNR = contrast to noise ratio, GPe = globus pallidus externa, GPi = globus pallidus interna, RN = red nucleus, SN = substantia nigra, STN = subthalamic nucleus.

Table 3. Comparison of manual and semi-automated within and across field strength (dice scores and volumes).

Structure Dice Scores Volumes
One-tailed Two-tailed
o3T 1 7T 1 3T v 7T MIST 2BF o3T Manual o3T MIST o3T MIST v Manual BF 7T Manual 7T MIST 7T MIST v 7T Manual BF o3T v 7T MIST BF
GPe/i 0.74 (0.02) 0.82 (0.03) M1 BF10 = 631.44 (Mc BF10 = 22501) 1466.20 (161.59) 1171.91 (72.41) BF10 1467.49 1258.50 BF10 BF10
456.18 (193.23) (80.45) 36.11 69.08
RN 0.81 (0.06) 0.85 (0.04) M1 BF10 = 9.15 (Mc BF10 = 82.93) 233.40 (45.45) 236.55 (54.65) BF01 236.26 239.77 BF01 BF01
0.14 (31.16) (39.16) 0.33 0.33
SN 0.78 (0.02) 0.75 (0.12) M2 BF01 = 0.61 (Mc BF10 = 3.17) 434.55 (475.36) 503.60 (101.65) BF10 445.47 497.64 BF01 BF01
4.10 (58.41) (127.78) 0.74 0.31
STN 0.67 (0.08) 0.70 (0.07) M1 BF10 = 1.04 (Mc BF10 = 6.61) 88.95 (15.15) 75.25 (16.49) BF10 90.01 91.06 BF01 BF01
11.96 (15.69) (24.15) 0.31 0.88

1 overlap between manual and semi-automated parcellations,

2 7T MIST is the preferred model.

Dice scores, conjunct volumes, Anatomical distances, and QSM CNRs are averaged across hemispheres and presented as mean values and standard deviations for o3T and 7T MRI contrasts. BF10 indicates evidence for the alternative, and BF01 refers to evidence for the null hypothesis. Dice scores of the agreement between manual and MIST parcellations are compared across o3T and 7T with a one-tailed paired samples t-tests where BF10 assumes that 7T is higher than o3T (model 1 (M1)), and BF01 assumes no difference or a decrease in 7T compared to o3T (model 2 (M2)). The volume, Anatomical distance and QSM CNRs are calculated for manual and MIST parcellations, and are compared both within o3T and 7T, as well as across field strength for MIST parcellations only. Volumes and Anatomical distances are compared with a two-tailed paired samples t-test. CNRs are additionally compared with a one-tailed paired samples t-tests wherein each case the BF10 assumes that 7T CNRs are higher than o3T (model 1 (M1)), and BF01 assumes no difference or a decrease in 7T compared to o3T (model 2 (M2)). For one-tailed paired samples t-tests, only the BF for the winning model is noted, and the likelihood ratio is calculated between the winning and losing models and is noted by Mc = model comparisons). QSM = quantitative susceptibility mapping, CNR = contrast to noise ratio, GPe/i = combined globus pallidus externa and interna, RN = red nucleus, SN = substantia nigra, STN = subthalamic nucleus.

Table 4. Comparison of manual and semi-automated within and across field strength (anatomical distance and QSM CNRs).

Structure Anatomical Distance QSM CNRs
Two-tailed One-tailed
o3T Manual o3T MIST o3T MIST v Manual BF 7T Manual 7T MIST 7T MIST v Manual BF o3T v 7T MIST BF o3T Manual o3T MIST o3T MIST v Manual BF 7T Manual 7T MIST 7T MIST v Manual BF o3T v 7T MIST 1 BF
GPe/i 35.61 (1.70) 35.32 (1.38) BF01 35.32 35.45 BF01 BF01 1.39 1.21 BF10 1.36 (0.17) 1.25 (0.20) BF10 M1 BF01 = 0.70 (Mc BF10 = 3.88)
0.43 -1.16 -1.32 0.37 0.42 -0.17 -0.13 138.13 1.42
RN 8.73 (0.40) 8.67 (0.51) BF01 8.77 (0.44) 8.91 (0.69) BF01 BF10 1.89 (0.50) 1.86 (0.47) BF01 1.89 (0.34) 1.89 (0.36) BF01 M1 BF01 = 0.38 (Mc BF10 = 1.48)
0.34 0.37 1.22 0.32 0.3
SN 16.48 (0.82) 16.34 (0.74) BF01 16.44 (0.45) 17.10 (1.27) BF10 BF10 1.91 (0.18) 1.80 (0.15) BF10 1.94 (0.26) 1.50 (0.35) BF10 M1 BF10 = 6.02 (Mc BF10 = 52.39)
0.4 1.33 2.03 3.58 3.54
STN 17.93 (1.33) 17.55 (0.83) BF01 17.72 (1.44) 17.98 (1.31) BF01 BF01 1.05 (0.15) 1.11 (0.27) BF01 1.36 (0.19) 1.19 (0.20) BF10 M1 BF01 = 0.61 (Mc BF10 = 3.17)
0.51 0.6 0.6 0.66 29.89

1 7T MIST is the preferred model, Two-tailed paired samples t-tests were used for these comparisons

Dice scores, conjunct volumes, Anatomical distances, and QSM CNRs are averaged across hemispheres and presented as mean values and standard deviations for o3T and 7T MRI contrasts. BF10 indicates evidence for the alternative, and BF01 refers to evidence for the null hypothesis. Dice scores of the agreement between manual and MIST parcellations are compared across o3T and 7T with a one-tailed paired samples t-tests where BF10 assumes that 7T is higher than o3T (model 1 (M1)), and BF01 assumes no difference or a decrease in 7T compared to o3T (model 2 (M2)). The volume, Anatomical distance and QSM CNRs are calculated for manual and MIST parcellations, and are compared both within o3T and 7T, as well as across field strength for MIST parcellations only. Volumes and Anatomical distances are compared with a two-tailed paired samples t-test. CNRs are additionally compared with a one-tailed paired samples t-tests wherein each case the BF10 assumes that 7T CNRs are higher than o3T (model 1 (M1)), and BF01 assumes no difference or a decrease in 7T compared to o3T (model 2 (M2)). For one-tailed paired samples t-tests, only the BF for the winning model is noted, and the likelihood ratio is calculated between the winning and losing models and is noted by Mc = model comparisons). QSM = quantitative susceptibility mapping, CNR = contrast to noise ratio, GPe/i = combined globus pallidus externa and interna, RN = red nucleus, SN = substantia nigra, STN = subthalamic nucleus.

Fig 4. MIST parcellations.

Fig 4

Outline of masks for each structure manually parcellated optimized 3T (o3T) (left) and 7T (right) from a single subject. Manual masks are shown in opaque purple for o3T and yellow for 7T. MIST masks are shown as an orange outline for o3T and pink outline for 7T. Structures are shown in the coronal, sagittal, and axial planes. QSM contrasts were used for all parcellations. QSM = quantitative susceptibility mapping, GPe/i = combined globus pallidus externa and interna, RN = red nucleus, SN = substantia nigra, STN = subthalamic nucleus.

Manual parcellations: o3T v 7T

Dice scores

Dice scores for the GPe (BF10 = 4.11), GPi (BF10 = 4.22) and RN (BF10 = 7.20) all reported substantial evidence in favor of 7T parcellations having a higher Dice than o3T. Additionally, these models were 33, 54 and 64 times (respectively) more likely than either no difference, or o3T having a higher Dice than 7T (referred to in the following sections as the alternative). For the SN (BF10 = 1.06) and STN (BF01 = 1.85), only anecdotal evidence was found in favor of 7T over o3T, which were 7 and 13 times more likely than the alternative, respectively. All winning models noted here were at least moderately more likely than the second model.

Volumes

When assessing for differences in volumes across field strength per structure, we found consistent anecdotal evidence for no difference for the GPe (BF01 = 0.58), GPi (BF01 = 0.31), RN (BF01 = 0.47), SN (BF01 = 0.35) and STN (BF01 = 0.51). Substantial evidence was found for differences in volumes per rater for o3T parcellations for the RN (BF10 = 3.89), and SN (BF10 = 6.72), and at 7T, strong evidence was found for the SN (BF10 = 29.87). All other structures showed either anecdotal or no evidence for differences across raters. Surprisingly, the GPe, GPi, SN, and STN showed higher standard deviations at 7T than o3T. Additionally, Pearson’s Rho correlation indicated that for o3T, Dice scores correlated with volumes for tor the GPe (r = 0.49), GPi (r = 0.76), RN (r = 0.45), SN (r = 0.14) and STN (r = 0.61), and at 7T for the GPe (r = 0.61), GPi (r = 0.86), RN (r = 0.41), SN (r = 0.80) and STN (r = 0.42). This is indicative of a bias where larger structures have a higher Dice score.

Anatomical distance

When assessing for differences in distances across field strengths per structure, we found consistent evidence for no differences for the GPe (BF01 = 0.86, anecdotal), GPi (BF01 = 0.89, anecdotal), RN (BF01 = 0.32, substantial), SN (BF01 = 0.31, substantial), and STN (BF01 = 0.34, anecdotal).

QSM CNRs

When assessing for differences in QSM CNRs for manual parcellations across field strength per structure, we found very strong evidence for higher CNRs for the STN for 7T than o3T (BF10 = 61.75), which was 630 times, and decisively more likely than no difference, or higher CNRs at o3T. However, the RN (BF10 = 1.64) and SN (BF10 = 1.20) showed only anecdotal evidence for increased CNRs at 7T than 3T, which are 12 and 8 times more likely than no differences or higher CNRs at o3T, respectively. For the GPi (BF01 = 0.66) anecdotal and for the GPe (BF10 = 5.43), substantial evidence was found for increased CNR at o3T than 7T, which was 47 times more likely than higher CNRs at 7T.

MIST parcellations

Dice scores

Dice scores were calculated per field strength, per structure with a one-tailed paired samples t-test for manual and semi-automated parcellations. For the GPe/i (BF10 = 631.44), we found decisive evidence that 7T Dice scores were higher than o3T, which was 22501 times more likely than no difference, or higher Dice scores at o3T (referred to as the alternative). For the RN (BF10 = 9.15), we found substantial evidence that 7T Dice scores were higher than o3T, which is 83 times more likely than the alternative. For the SN (BF01 = 0.61), we found anecdotal evidence for the alternative, with increased Dice scores at o3T than 7T which is 3 times more likely than the initial hypothesis that 7T Dice scores are higher than o3T. For the STN (BF10 = 1.04), only anecdotal evidence was found for higher Dice scores at 7T than o3T which was 7 times more likely than the alternative (see Fig 4).

Volumes

Two-tailed paired samples t-tests were conducted to assess differences in the volume of manual parcellations compared to the MIST output parcellations per field strength. For o3T, resulting MIST parcellation volumes were smaller than those resulting from manual parcellations for GPe/i (BF10 = 456.18, decisive) and STN (BF10 = 11.96, strong). For o3T SN volumes larger for MIST than for manual parcellations (BF10 = 4.10, substantial). For the o3T RN (BF01 = 0.14, substantial) we have evidence for no difference. For 7T, we found evidence for no difference between manual and MIST parcellations for the RN (BF01 = 0.33, substantial), SN (BF01 = 0.74, anecdotal), and STN (BF01 = 0.31, substantial). However, the GPe/i showed very strong evidence for increased volumes for manual parcellations than MIST (BF10 = 36.11). Next, the volumes of MIST parcellations were compared across o3T and 7T. Again, for the RN (BF01 = 0.33, substantial), SN (BF01 = 0.31, substantial), and STN (BF01 = 0.88, anecdotal), no differences in volumes were found. Finally, for the GPe/i, we found very strong evidence for increased volumes at 7T than o3T for MIST parcellations (BF10 = 69.08).

Anatomical distances

Two-tailed paired samples t-tests were conducted to assess for differences in the anatomical distance of manual parcellations with the MIST output parcellations per field strength. For o3T, the GPe/i (BF01 = 0.43), RN (BF01 = 0.34), SN (BF01 = 0.40), and STN (BF01 = 0.51) all showed anecdotal evidence for no difference. For 7T, anecdotal evidence for no difference was found for the GPe/i (BF01 = 0.37), RN (0.37) and STN (0.60), and for the SN we found anecdotal evidence for an increase in distance for MIST parcellations compared to manual (BF10 = 1.33).

QSM CNRs

Two-tailed paired samples t-tests were conducted to assess differences in the CNR of manual parcellations with the MIST output parcellations per field strength. For o3T, the GPe/i (BF10 = 138.13, decisive) and the SN (BF10 = 3.58, substantial) showed evidence for increased CNRs with manual over MIST parcellations. The o3T RN (BF01 = 0.32, substantial) and STN (BF01 = 0.66, anecdotal) showed evidence for no difference in CNRs. For 7T, the GPe/i (BF10 = 1.42) showed anecdotal evidence for higher CNRs for manual parcellations than MIST, the RN (BF01 = 0.30) showed substantial evidence for no difference, and the SN (BF10 = 3.54, substantial) and STN (BF10 = 29.89, strong) evidence for increased CNRs for manual parcellations than MIST. Next, CNRs of MIST parcellations were compared across o3T and 7T. The GPe/i (BF01 = 0.70), RN (BF01 = 0.38) and STN (BF01 = 0.61) all showed anecdotal evidence for no difference in CNR across field strength. The SN (BF10 = 6.02) showed substantial evidence for increased CNR at o3T than 7T, and was 51 times more likely than 7T CNRs being higher than o3T. Each winning model showed substantial evidence that it was more likely than the alternative.

Discussion

We set out to investigate whether a clinically feasible 7T sequence can outperform optimized and clinically feasible 3T MRI protocols for the visualization of a selection of subcortical DBS or landmarks including the GPe, GPi, RN, SN, and STN. Our main findings can be summarized as follows: 1) clinical 3T MRI did not allow for accurate manual 3D parcellation of subcortical nuclei primarily due to anisotropic voxel sizes. 2) 7T outperformed optimized 3T MRI protocol for manual parcellations for larger structures (GPe, GPi and RN); 3) very strong evidence for increased QSM CNR at 7T was found for the STN when manually parcellated; 4) When using MIST for semi-automatic parcellations, Dice scores did not indicate that 7T outperformed optimized 3T.

A stated previously, clinical MRI commonly employs anisotropic voxels to increase SNR along a single direction within a shorter timeframe. As a consequence, voxels in other dimensions are elongated and suffer from partial voluming effects [57, 58]. As a result biologically plausible 3D renderings of the brain structures could not be obtained, calculations of Dice coefficients for the c3T are meaningless and were therefore not obtained. We have included the scan parameters and parcellations in a qualitative manner to illustrate the variation in target visibility across scan. We considered delineating the individual brain structures on c3T images, and performing statistical comparisons. However, c3T parcellations did not yield anatomically plausible renderings of these structures. It is conceivable that these results would have revealed a high level of interrater agreement, as well as statistically significant differences. However, given the lack of anatomical relevance of these parcellations we deemed such analyses valueless.

Arguably, identification for DBS targeting is sufficient due to the increased SNR along the axial plane, with a fast scan time of around 4 minutes [58]. However, anisotropic voxels are severely limited in their ability to portray an accurate 3D representation of the target structure and are prone to partial voluming effects [57]. Therefore, quantitative analysis of the c3T were not performed, as biological plausible 3D renderings could not be obtained. We have included the scan parameters and parcellations in a qualitative manner to illustrate the variation in target visibility across scans (see Fig 2) [5961].

For manual parcellations, we found varying evidence in support of higher inter-rater agreement at 7T compared to the o3T MRI for the GPe/i, RN, SN and STN, which suggests that larger nuclei, and to a lesser extent, smaller nuclei have a higher visibility at increased field strengths. Additionally, the volumes were smaller for all structures at 7T, which could be explained by smaller voxels and increased SNR, which counters the effects of partial voluming observed both with lower field strengths and larger voxel sizes [57]. If the changes in volume were the result of altered visibility of a specific anatomical border, this would result in a position shift of the center-of-mass. Since such a shift would be present in both hemispheres, we expected it to be reflected in a change in anatomical distance. It is important to note that it is possible that an equal but opposite effect in the other hemisphere could obscure shifts the center-of-mass. Interestingly, the CNR values were lower for 7T than o3T for the GPe/i. CNRs for the RN, SN, and STN were slightly higher at 7T than o3T, though did not result in a higher agreement between raters. This discrepancy may be explained by a raters bias with regards to prior information about size, shape and surrounding anatomy [62]. Moreover, while QSM is a quantitative measure, a strict consensus on the susceptibility values of specific structures is still lacking [63]. Additionally, smaller voxel sizes provide more precise information regarding the size and shape of structures. However, the number of voxels required to define a structure will increase, which may not directly improve the accuracy of manual parcellation. For example the STN Dice scores showed only a minor increase at 7T compared to o3T, despite there being evidence for increased CNR at 7T. Moreover, higher resolution allows for more freedom in where to place structural boundaries. Whereas larger voxels make labeling more reproducible, though not necessarily more anatomically accurate, we did not pursue any quantitative analyses of the c3T data.

For semi-automated parcellations, two sets of comparisons were computed. First, we set out to compare within field strength the differences between manual and MIST parcellations to assess for biases occurring with manual parcellations. Second, we compared MIST parcellations across field strength, as we initially did for the manual parcellations, to determine whether semi-automated protocols benefit from 7T MRI. Of note, the o3T MRI data was pre-registered to a common 1mm isotropic space to allow for computations using MIST. Similarly, to maintain the high spatial resolution but ensure compatibility, the 7T images were down sampled to 0.8 mm isotropic. We have previously demonstrated the substantial impact of voxel geometry on parcellation accuracy [57]. It is therefore possible that our results using MIST may have underestimated the effects resulting from the higher spatial resolution that can be achieved using 7T. The largely absent CNR differences indicate that differences in spatial resolution can, at least in part, explain the differences observed using MIST. Down sampling of the 7T data may have led to an underestimation of the effect of the higher spatial resolution that was obtained from 7T scanning.

Volumes for the GPe/i were very different across segmentation method. This inconsistency could be explained by the fact that manual raters parcellated the GPe and GPi separately, but were combined in MIST parcellating the GP as a single structure. Moreover, the MIST prior for the GP includes the medial medullary lamina which we did not include in our manual parcellations. Dice scores were calculated for the manual and MIST parcellations per field strength, and then compared across o3T and 7T. The RN and STN Dice scores were higher for 7T than o3T across parcellation method. Interestingly the SN Dice scores were higher for o3T than 7T. o3T MIST parcellations had smaller volumes for the GPe/i, RN and STN, and larger for the SN compared to manual parcellations. For 7T, MIST volumes were more consistent with manual parcellations. MIST parcellated volumes did not differ across field strength for the RN, SN, and STN, however the GPe/i did, which suggests larger structures may be more accurately parcellated with 7T than o3T. Generally, CNRs were higher for manual than for MIST parcellations at o3T, apart from the STN which had a higher CNR for MIST. Similarly, for 7T all CNRs were higher or equal for manual parcellations than for MIST. We found no difference in CNRs across field strength for the MIST parcellations of the palladium, RN and STN.

Interestingly, the MIST SN had higher a CNR for o3T than 7T. These findings suggest that overall, the semi-automated parcellation procedures that were applied do not appear to rely as heavily on CNR as manual parcellations and are therefore not subject to the same biases as manual parcellation. However, the SN and STN at o3T may be an exception. It may be that for smaller nuclei, semi-automated methods using lower field strengths or images with larger voxel sizes rely more on CNR for identification of structural boundaries, whereas higher field strengths or images with submillimeter resolution instead rely on the spatial information.

Applications

It is important to consider the relevance of these findings in light of neurosurgical applications. Previous work has shown that while the visualization of the STN at 7T shows increased SNR, target localization is not necessarily improved [6466]. We cannot conclude whether this lack of improvement can be attributed to the MRI imaging or is the result of other factors, including the variation between surgeons [66]. The current study, together with our previous findings, indicate that optimization of 3T MRI scans through the use of isotropic voxels and QSM do indeed allow for more accurate visualization of the STN [34, 57]. We developed a scan protocol optimized for its potential use in a clinical setting. Our protocol allowed the calculation of quantitative contrasts. In view of their higher sensitivity to subtle global brain changes, and their applicability within a clinical timeframe we decided to use quantitative contrasts. We did not compare quantitative MRI to conventional weighted MRI images, and we therefore cannot conclude that quantitative MRI positively influences parcellation results. However, the theoretical benefits of removing bias, and the potential application of quantitative MRI as a biomarker argues for the calculation of quantitative MRI contrasts.

We would like to note that despite improved anatomical orientation, individual variation in the internal structure of the STN may continue to require awake testing of patients during surgery to obtain the desired clinical effect. Additionally, we have shown that an o3T scan can be obtained in a timeframe that is sensible within clinical practice and can account for age related increases in pathological iron deposition by using multiple and increasing echo times without superseding SAR limitations. This is a particularly important finding given the limitations of both c3T and 7T imaging, which include proneness to increased geometric distortions which reduce spatial accuracy and increase artefacts, B1 field inhomogeneity, power deposition, and altered specific absorption rates [2, 67]. In the MP2RAGEME, B0 inhomogeneities are automatically cancelled through the use of a ratio image [68]. Additionally, the subcortical parcellations presented in the current studies are largely dependent on grey matter contrasts, and we optimized contrast using flip angles of 4/4 instead of 7/6 degrees. Moreover, patient-related contraindications such as metal and or electronic implants, prostheses and foreign bodies, vascular or renal disorders, weight and claustrophobia can limit the potential patient population able to undergo a 7T MRI [3, 69, 70]. Thus, while our results indicate that 7T is to an extent superior to 3T, o3T could provide a more clinically viable option.

Considerations

The cohort tested in this study consists of young healthy participants, and it is well known that older participants and PD patients have increased iron content in basal structures [71]. Since the effects on QSM increase with age and disease, we may underestimate the clinical relevance of these findings [34]. Moreover, the o3T consists of two separate scans, whereas the 7T acquisition includes a multi contrast scan obtained within a single session. A multi contrast scan at lower fields would have resulted in an increased scanning time, and therefore be arguably more difficult for scanning with patient populations, especially those with movement disorders. Additionally, a direct comparison between the 3T and 7T data would require co-registration to the same space involving resampling of the data. Since the outcomes of such a comparison could differ substantially dependent on the registration approach chosen, we decided not to perform such analyses. Further, it is important to note that while 3T image quality could be more closely matched with 7T MRI, the resulting protocol would have limited use for clinical application. Specifically, increasing the signal and contrast would require an more repetitions, resulting in longer acquisition times. This will further increase SAR and the impact of motion artifacts, making the potential gains in SNR and CNR arbitrary, as the scan protocol cannot be deployed clinically.

Conclusions

We set out to test whether 7T outperformed 3T MRI in the context of target visualization for DBS surgery. We now conclude that 7T outperforms 3T protocols. c3T protocols do not allow the rendering of biologically plausible 3D representation of small deep brain structures, they therefore cannot provide an accurate 3D account of the surgical area. o3T protocols using isotropic voxels strongly improved the imaging of the surgical area, although it was still outperformed by 7T imaging. The constraints posed by the clinical applicability of the imaging protocol contributed to limitations including differences in voxel sizes, scan sequences, field homogeneity. The results presented in the current studies should therefore be interpreted within the clinical framework, as they are not an account of the limits of 3T and 7T imaging within a research setting. Given the limited availability and compatibility restrictions in the patient population of 7T MRI systems for clinical application, our results have merit for more short-term imBprovement of clinical neuroimaging procedures for surgical purposes. Finally, the use of isotropic voxels is of great importance in these efforts, and we call for caution in the application of anisotropic voxels.

Supporting information

S1 File

(PDF)

Data Availability

All anonymized data and analysis scripts are available from https://osf.io/4nrku/, under the terms of the Creative Commons Attribution License and complies with the rules of the General Data Protection Regulation (EU) 2016/679.

Funding Statement

This research was supported by a Vidi and Vici grant from the Dutch Organization for Scientific Research (BUF), and an NWO-STW grant from the Dutch Organization for Scientific Research (BUF, MJM, AA).

References

  • 1.Forstmann BU, Isaacs BR, Temel Y. Ultra High Field MRI-Guided Deep Brain Stimulation. Trends Biotechnol. Elsevier Ltd; 2017;35: 904–907. 10.1016/j.tibtech.2017.06.010 [DOI] [PubMed] [Google Scholar]
  • 2.Keuken MC, Isaacs BR, Trampel R, van der Zwaag W, Forstmann BU. Visualizing the Human Subcortex Using Ultra-high Field Magnetic Resonance Imaging. Brain Topogr. 2018; 10.1007/s10548-018-0638-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ladd ME, Bachert P, Meyerspeer M, Moser E, Nagel AM, Norris DG, et al. Pros and cons of ultra-high-field MRI/MRS for human application. Prog Nucl Magn Reson Spectrosc. The Authors; 2018;109: 1–50. 10.1016/j.pnmrs.2018.06.001 [DOI] [PubMed] [Google Scholar]
  • 4.Kraff O, Fischer A, Nagel AM, Mönninghoff C, Ladd ME. MRI at 7 Tesla and above: Demonstrated and potential capabilities. J Magn Reson Imaging. 2015;41: 13–33. 10.1002/jmri.24573 [DOI] [PubMed] [Google Scholar]
  • 5.Trattnig S, Springer E, Bogner W, Hangel G, Strasser B, Dymerska B, et al. Key clinical benefits of neuroimaging at 7 T. Neuroimage. 2018;168: 477–489. 10.1016/j.neuroimage.2016.11.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Peerlings J, Compter I, Janssen F, Wiggins CJ, Postma AA, Mottaghy FM, et al. Characterizing geometrical accuracy in clinically optimised 7T and 3T magnetic resonance images for high-precision radiation treatment of brain tumours. Phys Imaging Radiat Oncol. Elsevier; 2019;9: 35–42. 10.1016/j.phro.2018.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.De Ciantis A, Barba C, Tassi L, Cosottini M, Tosetti M, Costagli M, et al. 7T MRI in focal epilepsy with unrevealing conventional field strength imaging. Epilepsia. 2016;57: 445–454. 10.1111/epi.13313 [DOI] [PubMed] [Google Scholar]
  • 8.Inglese M, Fleysher L, Oesingmann N, Petracca M. Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis. Expert Rev Neurother. Taylor & Francis; 2018;18: 221–230. 10.1080/14737175.2018.1433033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Madai VI, von Samson-Himmelstjerna FC, Bauer M, Stengl KL, Mutke MA, Tovar-Martinez E, et al. Ultrahigh-field mri in human ischemic stroke—a 7 Tesla study. PLoS One. 2012;7 10.1371/journal.pone.0037631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McKiernan EF, O’Brien JT. 7T MRI for neurodegenerative dementias in vivo: A systematic review of the literature. J Neurol Neurosurg Psychiatry. 2017;88: 564–574. 10.1136/jnnp-2016-315022 [DOI] [PubMed] [Google Scholar]
  • 11.Horn A. The impact of modern-day neuroimaging on the field of deep brain stimulation. Curr Opin Neurol. 2019;32: 1 10.1097/WCO.0000000000000648 [DOI] [PubMed] [Google Scholar]
  • 12.Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006; S290–304. 10.1002/mds.20962 [DOI] [PubMed] [Google Scholar]
  • 13.Odekerken VJJ, Boel JA, Schmand BA, De Haan RJ, Figee M, Van Den Munckhof P, et al. GPi vs STN deep brain stimulation for Parkinson disease. Neurology. 2016;86: 755–761. 10.1212/WNL.0000000000002401 [DOI] [PubMed] [Google Scholar]
  • 14.Odekerken VJJ, van Laar T, Staal MJ, Mosch A, Hoffmann CFE, Nijssen PCG, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): A randomised controlled trial. Lancet Neurol. 2013;12: 37–44. 10.1016/S1474-4422(12)70264-8 [DOI] [PubMed] [Google Scholar]
  • 15.Vidailhet M, Vercueil L, Houeto J-L, Krystkowiak P, Benabid A-L, Cornu P, et al. Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia. N Engl J Med. 2005;352: 459–467. 10.1056/NEJMoa042187 [DOI] [PubMed] [Google Scholar]
  • 16.Loddenkemper T., Pan A., Neme S., Baker K. B., Rezai A. R., Dinner D. S., et al. Deep Brain Stimulation in Epilepsy. Deep Brain Stimulation in Neurological and Psychiatric Disorders. 2008. pp. 561–569. 10.1007/978-1-59745-360-8_28 [DOI] [Google Scholar]
  • 17.Ligot N, Krystkowiak P, Simonin C, Goldman S, Peigneux P, Van Naemen J, et al. External globus pallidus stimulation modulates brain connectivity in Huntington’s disease. J Cereb Blood Flow Metab. 2011;31: 41–46. 10.1038/jcbfm.2010.186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pollo C, Meuli R, Maeder P, Vingerhoets F, Ghika J, Villemure JG. Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease: Magnetic Resonance Imaging Targeting Using Visible Anatomical Landmarks. Stereotact Funct Neurosurg. 2003;80: 76–81. 10.1159/000075163 [DOI] [PubMed] [Google Scholar]
  • 19.Aquino D, Bizzi A, Grisoli M, Garavaglia B, Bruzzone MG, Nardocci N, et al. Age-related Iron Deposition in the Basal Ganglia: Quantitative Analysis in Healthy Subjects. Radiology. 2009;252: 165–172. 10.1148/radiol.2522081399 [DOI] [PubMed] [Google Scholar]
  • 20.Keuken MC, Bazin PL, Backhouse K, Beekhuizen S, Himmer L, Kandola A, et al. Effects of aging on T1, T2∗, and QSM MRI values in the subcortex. Brain Struct Funct. 2017;222: 2487–2505. 10.1007/s00429-016-1352-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zwirner J, Möbius D, Bechmann I, Arendt T, Hoffmann K-T, Jäger C, et al. Subthalamic nucleus volumes are highly consistent but decrease age-dependently-a combined magnetic resonance imaging and stereology approach in humans. Hum Brain Mapp. John Wiley & Sons, Ltd; 2017;38: 909–922. 10.1002/hbm.23427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Deistung A, Schafer A, Schweser F, Biedermann U, Turner R, Reichenbach JR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. 2012/10/06. 2013;65: 299–314. 10.1016/j.neuroimage.2012.09.055 [DOI] [PubMed] [Google Scholar]
  • 23.Neumann J, Schäfer A, Bowtell R, Turner R, Wharton S, Forstmann BU, et al. Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum Brain Mapp. Wiley Subscription Services, Inc., A Wiley Company; 2011;33: 2831–2842. 10.1002/hbm.21404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Schweser F, Sommer K, Deistung A, Reichenbach JR. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage. 2012;62: 2083–2100. 10.1016/j.neuroimage.2012.05.067 [DOI] [PubMed] [Google Scholar]
  • 25.Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, et al. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care. J Magn Reson Imaging. 2017;46: 951–971. 10.1002/jmri.25693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Temel Y, Blokland A, Steinbusch HWM, Visser-Vandewalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol. 2005;76: 393–413. 10.1016/j.pneurobio.2005.09.005 [DOI] [PubMed] [Google Scholar]
  • 27.Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, et al. Complications of deep brain stimulation surgery. Stereotactic and Functional Neurosurgery. 2002. pp. 73–78. 10.1159/000064600 [DOI] [PubMed] [Google Scholar]
  • 28.Low HL, Ismail MN bin M, Taqvi A, Deeb J, Fuller C, Misbahuddin A. Comparison of posterior subthalamic area deep brain stimulation for tremor using conventional landmarks versus directly targeting the dentatorubrothalamic tract with tractography. Clin Neurol Neurosurg. Elsevier; 2019;185: 105466 10.1016/j.clineuro.2019.105466 [DOI] [PubMed] [Google Scholar]
  • 29.Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Ann Neurol. John Wiley & Sons, Ltd; 1998;44: 622–628. 10.1002/ana.410440407 [DOI] [PubMed] [Google Scholar]
  • 30.Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas J-F, Perret JE, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. Elsevier; 1995;345: 91–95. 10.1016/s0140-6736(95)90062-4 [DOI] [PubMed] [Google Scholar]
  • 31.Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, et al. Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson’s Disease. N Engl J Med. Massachusetts Medical Society; 1998;339: 1105–1111. 10.1056/NEJM199810153391603 [DOI] [PubMed] [Google Scholar]
  • 32.Lyons KE, Wilkinson SB, Overman J, Pahwa R. Surgical and hardware complications of subthalamic stimulation: A series of 160 procedures. Neurology. 2004. pp. 612–616. 10.1212/01.wnl.0000134650.91974.1a [DOI] [PubMed] [Google Scholar]
  • 33.Wiggins GC, Polimeni JR, Potthast A, Schmitt M, Alagappan V, Wald LL. 96-Channel receive-only head coil for 3 Tesla: Design optimization and evaluation. Magn Reson Med. 2009;62: 754–762. 10.1002/mrm.22028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Alkemade A, de Hollander G, Keuken MC, Schäfer A, Ott DVM, Schwarz J, et al. Comparison of T2*-weighted and QSM contrasts in Parkinson’s disease to visualize the STN with MRI. Jiang Q, editor. PLoS One. Public Library of Science; 2017;12: e0176130 10.1371/journal.pone.0176130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Alkemade A, Mulder MJ, Groot JM, Isaacs BR, van Berendonk N, Lute N, et al. The Amsterdam Ultra-high field adult lifespan database (AHEAD): A freely available multimodal 7 Tesla submillimeter magnetic resonance imaging database. Neuroimage. Academic Press; 2020;221: 117200 10.1016/j.neuroimage.2020.117200 [DOI] [PubMed] [Google Scholar]
  • 36.Caan MWA, Bazin P, Marques JP, Hollander G, Dumoulin S, Zwaag W. MP2RAGEME: T 1, T 2 *, and QSM mapping in one sequence at 7 tesla. Hum Brain Mapp. John Wiley & Sons, Ltd; 2018; hbm.24490. 10.1002/hbm.24490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Marques JP, Kober T, Krueger G, Van Der Zwaag W, Van De Moortele P-F, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T 1-mapping at high field. Neuroimage. 2009;49: 1271–1281. 10.1016/j.neuroimage.2009.10.002 [DOI] [PubMed] [Google Scholar]
  • 38.Li W, Wang N, Yu F, Han H, Cao W, Romero R, et al. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping. Neuroimage. 2015;108: 111–122. 10.1016/j.neuroimage.2014.12.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Li W, Avram A V, Wu B, Xiao X, Liu C. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed. NIH Public Access; 2014;27: 219–27. 10.1002/nbm.3056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Forstmann BU, Keuken MC, Schafer A, Bazin PL, Alkemade A, Turner R. Multi-modal ultra-highresolution structural 7-Tesla MRI data repository. Sci Data. 2014; 10.1038/sdata.2014.50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Visser E, Keuken MC, Douaud G, Gaura V, Bachoud-Levi A-C, Remy P, et al. Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation Tool. Neuroimage. 2016;125: 479–497. 10.1016/j.neuroimage.2015.10.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Visser E, Keuken MC, Forstmann BU, Jenkinson M. Automated segmentation of the substantia nigra, subthalamic nucleus and red nucleus in 7T data at young and old age. Neuroimage. 2016;139: 324–336. 10.1016/j.neuroimage.2016.06.039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Dice LR, Dice. Measurements of Amount of Ecologic Association between Species. Ecology. Ecological Society of America; 1945;26: 297–302. 10.2307/1932409 [DOI] [Google Scholar]
  • 44.Keuken MC, Bazin PL, Schafer A, Neumann J, Turner R, Forstmann BU. Ultra-high 7T MRI of structural age-related changes of the subthalamic nucleus. J Neurosci. 2013;33: 4896–4900. 10.1523/JNEUROSCI.3241-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ledez D. Euclidean distance mapping: geological applications. Terra Nostra (Proc IAMG). 2002;4: 25–30. [Google Scholar]
  • 46.Huntenburg JM, Steele CJ, Bazin P-L. Nighres: processing tools for high-resolution neuroimaging. Gigascience. Narnia; 2018;7 10.1093/gigascience/giy082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Morey RD, Wagenmakers E-J. Simple relation between Bayesian order-restricted and point-null hypothesis tests. Stat Probab Lett. North-Holland; 2014;92: 121–124. 10.1016/J.SPL.2014.05.010 [DOI] [Google Scholar]
  • 48.Team RC. R: A language and Environment for Statistical Computing. J Comput Graph Stat. 2015;5: 299–314. [Google Scholar]
  • 49.Jeffreys H. Theory of probability. Oxford, UK: Oxford University Press; 1961; [Google Scholar]
  • 50.Wetzels R, Matzke D, Lee MD, Rouder JN, Iverson GJ, Wagenmakers E-J. Statistical Evidence in Experimental Psychology. Perspect Psychol Sci. SAGE PublicationsSage CA: Los Angeles, CA; 2011;6: 291–298. 10.1177/1745691611406923 [DOI] [PubMed] [Google Scholar]
  • 51.Isaacs BR, Trutti AC, Pelzer E, Tittgemeyer M, Temel Y, Forstmann BU, et al. Cortico-basal white matter alterations occurring in Parkinson’s disease. PLoS One. Public Library of Science; 2019;14 10.1371/journal.pone.0214343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Akaike H. Likelihood and the Bayes procedure. Springer, New York, NY; 1998. pp. 309–332. 10.1007/978-1-4612-1694-0_24 [DOI] [Google Scholar]
  • 53.Rouder JN, Morey RD, Speckman PL, Province JM. Default Bayes factors for ANOVA designs. J Math Psychol. Academic Press; 2012;56: 356–374. 10.1016/j.jmp.2012.08.001 [DOI] [Google Scholar]
  • 54.Evans NJ, Wagenmakers E-J. Theoretically meaningful models can answer clinically relevant questions. Brain. 2019;142: 1170–1172. 10.1093/brain/awz096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Berry DA, Hochberg Y. Bayesian perspectives on multiple comparisons. J Stat Plan Inference. 1999;82: 215–227. 10.1016/S0378-3758(99)00044-0 [DOI] [Google Scholar]
  • 56.Perlmutter JS. Assessment of parkinson disease manifestations. Current Protocols in Neuroscience. 2009. 10.1002/0471142301.ns1001s49 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Mulder MJ, Keuken MC, Bazin P-L, Alkemade A, Forstmann BU. Size and shape matter: The impact of voxel geometry on the identification of small nuclei. Bergsland N, editor. PLoS One. Public Library of Science; 2019;14: e0215382 10.1371/journal.pone.0215382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ranjan M, Boutet A, Xu DS, Lozano CS, Kumar R, Fasano A, et al. Subthalamic Nucleus Visualization on Routine Clinical Preoperative MRI Scans: A Retrospective Study of Clinical and Image Characteristics Predicting Its Visualization. Stereotact Funct Neurosurg. Karger Publishers; 2018;96: 120–126. 10.1159/000488397 [DOI] [PubMed] [Google Scholar]
  • 59.Springer E, Dymerska B, Cardoso PL, Robinson SD, Weisstanner C, Wiest R, et al. Comparison of Routine Brain Imaging at 3 T and 7 T. Invest Radiol. 2016; 10.1097/RLI.0000000000000256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Knowles BR, Friedrich F, Fischer C, Paech D, Ladd ME. Beyond T2 and 3T: New MRI techniques for clinicians. Clin Transl Radiat Oncol. 2019; 10.1016/j.ctro.2019.04.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Polders DL, Leemans A, Luijten PR, Hoogduin H. Uncertainty estimations for quantitative in vivo MRI T1 mapping. J Magn Reson. 2012;224: 53–60. 10.1016/j.jmr.2012.08.017 [DOI] [PubMed] [Google Scholar]
  • 62.Despotović I, Goossens B, Philips W. MRI Segmentation of the Human Brain: Challenges, Methods, and Applications. Comput Math Methods Med. 2015; 10.1155/2015/450341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Fang J, Bao L, Li X, van Zijl PCM, Chen Z. Background field removal for susceptibility mapping of human brain with large susceptibility variations. Magn Reson Med. John Wiley and Sons Inc.; 2019;81: 2025–2037. 10.1002/mrm.27492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.van Laar PJ, Oterdoom DLM, ter Horst GJ, van Hulzen ALJ, de Graaf EKL, Hoogduin H, et al. Surgical Accuracy of 3-Tesla Versus 7-Tesla Magnetic Resonance Imaging in Deep Brain Stimulation for Parkinson Disease. World Neurosurg. Elsevier; 2016;93: 410–412. 10.1016/j.wneu.2016.06.084 [DOI] [PubMed] [Google Scholar]
  • 65.Bot M, Verhagen O, Caan M, Potters W, Dilai J, Odekerken V, et al. Defining the dorsal STN border using 7.0-Tesla MRI: a comparison to microelectrode recordings and lower field strength MRI. Brain Stimul. Karger Publishers; 2019;12: 587 10.1016/j.brs.2018.12.952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Hamel W, Köppen JA, Alesch F, Antonini A, Barcia JA, Bergman H, et al. Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists. World Neurosurg. Elsevier; 2017;99: 41–46. 10.1016/j.wneu.2016.11.012 [DOI] [PubMed] [Google Scholar]
  • 67.van Osch MJP, Webb AG. Safety of Ultra-High Field MRI: What are the Specific Risks? Current Radiology Reports. 2014. 10.1007/s40134-014-0061-0 [DOI] [Google Scholar]
  • 68.Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage. 2010;49: 1271–1281. 10.1016/j.neuroimage.2009.10.002 [DOI] [PubMed] [Google Scholar]
  • 69.Van Der Kolk AG, Hendrikse J, Zwanenburg JJM, Visser F, Luijten PR. Clinical applications of 7 T MRI in the brain. European Journal of Radiology. 2013. pp. 708–718. 10.1016/j.ejrad.2011.07.007 [DOI] [PubMed] [Google Scholar]
  • 70.Moser E, Stahlberg F, Ladd ME, Trattnig S. 7-T MR-from research to clinical applications? NMR in Biomedicine. 2012. pp. 695–716. 10.1002/nbm.1794 [DOI] [PubMed] [Google Scholar]
  • 71.Wang JY, Zhuang QQ, Zhu LB, Zhu H, Li T, Li R, et al. Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements. Sci Rep. Nature Publishing Group; 2016;6 10.1038/srep36669 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Xi Chen

3 Sep 2020

PONE-D-20-19977

3 versus 7 Tesla Magnetic Resonance Imaging for parcellations of subcortical brain structures

PLOS ONE

Dear Dr. Alkemade,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 18 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Xi Chen

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Isaacs et al. compared the 3 and 7 Tesla magnetic resonance imaging (MRI) in visualizing the small brain structures, with the goal of utilizing the additional imaging information afforded by the 7T MRI to eventually replace the need of behavioral testing in awake patient during deep brain stimulation (DBS) surgery. The manuscript was clearly written, and the data presentation was well-organized.

My major concern is the lack of clarity in the authors’ conclusion. They set out to ask the question whether the 7T MRI represented a better option for imaging anatomical structures such as globus pallidus (GP) and subthalamic nucleus (STN). The data seemed to suggest that the answer was “it depends.” For imaging some larger structures, the 7T did outperform, while for some other structures, it did not. However, the conclusion reached by the authors was mainly about the importance of isotropic voxels. I would recommend the authors to stay focused on the main goal of this study when it comes to the conclusions, and clearly write about whether the 7T offers additional imaging information that could potentially improve surgical procedures and patient care, and if so, to what extent.

Minor comments:

1. In the Results section of main text, under “Anatomical Distance” subtitle, when the authors reported the Bayes Factors (BFs) for GPi and STN, the interpretations seemed inconsistent with what the numbers indicated.

2. For Figure 2, please specify that the notations to the panels’ right are the voxel sizes.

Reviewer #2: Summary and overall impressions

This manuscript describes the utility of higher resolution and ultra-high field MRI for anatomical segmentations of subcortical structures with clinical applications. In particular, the manuscript compares current clinical approaches using standard 3T MRI with optimized 3T MRI and with 7T MRI and how the acquisitions affect manual and semi-automatic basal ganglia segmentations. Overall, the manuscript provides solid evidence that 7T MRI enables improvements in segmentation of subcortical brain structures, and that isotropic voxel sizes are critical for accurate subcortical segmentation. On the whole, these results are not particularly surprising, but they are important for improving clinical imaging and establishing the clinical utility of ultra-high field anatomical MRI. Certain individual statistical results also suggest weaknesses in current MRI acquisition and semi-automated processing approaches, which are important to keep in mind, particularly for clinical investigations.

The data are appropriate for this investigation and are well-described. The results are similarly interpreted appropriately. While some additional control analyses would bolster the major claims of the manuscript, and I have a few minor concerns regarding the reporting of methods and results, I can recommend this manuscript for publication if they are addressed.

Larger concerns

There are a number of uncontrolled variables that could be influencing segmentation differences between acquisitions and parcellation schemes. Two major ones—resolution and acquisition sequence—are mentioned presently, although their effects are not fully addressed.

Regarding resolution, which differs between the 7T and 3T acquisitions: a major result is the lack of CNR differences between 3T and 7T with semi-automated parcellation methods, as well as reduced segmentation consistency for smaller structures at 7T. To determine whether segmentation improvements are due to increased spatial resolution or signal contrast, it would be helpful to downsample the 7T data to the 3T resolution and compare it with both the native 7T resolution segmentations and the 3T segmentations. This downsampling would clarify the relative contributions of resolution and signal contrast.

Additionally, the manual and semi-automatic segmentations were performed on slightly different data: 3T manual segmentations were in native space, while 3T semi-automatic segmentations were on data warped to a common space. For the 7T data, manual segmentations were performed at native resolution, while semi-automatic segmentations were performed on (slightly) downsampled data. This last difference is particularly odd, given that at least one result in this manuscript is assigned to differences in resolution (3T vs. 7T small structure segmentation; Line 543) and needs controlling or further explanation.

The manuscript should address what added value the quantitative maps provide over conventional weighted images. Ideally, this would include a comparison (at 3T and at 7T) between segmentations performed by T2-weighted images (from a single echo) and T2* maps. This would be useful data for deciding the utility of quantitative maps (over conventional weighted images) in clinical contexts.

Despite a major take-home message being the importance of isotropic voxel sizes even at 3T, there is surprisingly no statistical comparison between the anisotropic (clinical) 3T scans and the isotropic (optimized) 3T scans. While not optimal, the anisotropic images do provide 3D data and could be segmented. There would likely be high variability between segmentations reflected in lower Dice scores than for the isotropic data, which would provide statistical evidence for the main conclusion of the manuscript.

Minor concerns

Regarding the presentation of statistical results, there are many comparisons made in this manuscript, each of which is appropriate. However, the tables could be difficult to read with confidence. These issues likely reflect my relative unfamiliarity with Bayesian statistics, but other readers may have similar interpretation issues, so addressing these concerns is important.

For example, noting which comparisons use one-tailed or two-tailed tests in the tables would be very helpful, as it’s currently challenging to to understand the direction/interpretation of effects at first glance. Perhaps separating or delineating the tables based on one-tailed vs. two-tailed tests would be easier to interpret.

In general, the tables are conveying a lot of statistical information but can be difficult to parse. For instance, in Table 3b, it is unclear where “Anatomical Distance” measures end and “QSM CNRs” begin. Extending the vertical separators to the highest level would help.

Further, despite relying on quantitative mapping paradigms, there is limited discussion of conventional “weighted” images vs. quantitative maps. The manuscript should discuss rationale for using maps and explain how they differ from conventional images. Incorporating a color bar in the figures (showing correspondence between image intensity and physical units) would help readers intuit the “quantitativeness” of T1 and T2* maps.

Line-specific comments

Line 142: Inconsistent reporting of TA/total acquisition time across data acquisitions in the methods (here “ms”, usually “min”). As “TA (Acquisition Time)” is ambiguous and can refer to active volume collection within a TR in a sparse fMRI design, something like “scan duration/length” or “total acquisition time” would be clearer.

Line 163: A bit more description of T1 map estimation would be helpful. In particular, T1 map estimation from the 3T data, as the o3T T1-weighted image only has one data point. Citations of previous uses of this mapping would also be beneficial. This paragraph should also be under a “Image processing” (or similarly named) section, not under “Data acquisition.”

Line 194: “QSM-maps and T1-images were used as input for MIST.” T1-weighted or T1 maps? It sounds like T1 maps but please clarify (but also see concern re: Line 163).

Line 214: Why resample to 0.8 mm? If isotropic voxel size is required, why not 0.7 mm? Additionally, right now the manual segmentation used full resolution (0.64x0.64x0.7), but MIST used 0.8 mm. To directly compare segmentation methods, statistical comparisons should be conducted on the same input data.

Line 232: Anatomical distance is computed as the center of mass between left and right hemisphere structures and is therefore sensitive to segmentation quality in each structure. Therefore, a center-of-mass difference in one hemisphere’s structure (when comparing two different scans/segmentation methods) could be masked by an equal but opposite center-of-mass difference in the other hemisphere’s structure. This is minor, and there aren’t indications that it dramatically affects the overall interpretation of results, but it should be addressed by using a control reference point (such as midline posterior commissure), or at least discussed.

Line 276: “Preferred model” could use clarification. Is it just the model with greater evidence (logarithmic distance from 1)? Tables 3a and 3b are also ambiguous in denoting the preferred model.

Line 280: For readers who are less familiar with Bayesian statistics, it would be helpful to describe differences in BF reporting between one-tailed and two-tailed tests: for one-tailed, BF > 1 suggests M1 (group 1 > group 2), while BF <1 suggests M2 (group 2 > group 1). Whereas for two-tailed, BF > 1 suggests a difference between groups without preferring one group over the other, while BF < 1 suggests no difference between groups.

Line 302: At present, the data and processing scripts are hosted on OSF but are not available without requesting access. Please make the project data and scripts public for inspection during the review process.

Table 2: QSM CNRs – GPe: o3T > 7T, but BF is described as “M_2 BF_10”. If model 2 is preferred, shouldn’t BF be reported as BF_01? (according to the caption) However, then the BF should be < 1.

Line 370: GPi (BF = 0.89) and STN (BF = 0.34) should be “anecdotal”, not “substantial” (per Bayes Factor Interpretation cut-off values in Table 1).

Line 398: Similar to Line 280, more specific statistical language would be helpful (at least for the first description of two-tailed results). For instance, could say “For o3T we found significant evidence for a difference between manual and MIST segmentations of GPe/i and STN, with both being smaller with MIST than with manual parcellations.”

Line 424: STN should be reported as BF_10, not BF_01, as per Table 3b and the present interpretation.

Table 3a: It’s ambiguous what the “preferred model” is, as the “**” annotation seems to be pointing to a statistical test, not to a specific model.

Table 3b: Same “**” preferred model issue – can’t tell which model is preferred.

Line 525: Re: segmentation method differences: address possible contributions of data resampling prior to MIST but not manual segmentation (resulting in different resolution, along with potential partial voluming effects and SNR changes).

Line 544: CNR vs. resolution could be assessed by downsampling 7T data to 3T resolution and comparing segmentations with high res 7T, o3T segmentations

Line 554: Lack of improvement at 7T could also be due to sequence differences – are there downsides to the combined T1w/T2w MP2RAGEME sequence? Does the lack of field inhomogeneity correction contribute?

Line 561: first mention of field inhomogeneity. Given that Caan et al. (2019) say that “Good B1+‐inhomogeneity correction of both MP2RAGE and MP2RAGEME data is essential for successful cortical segmentation using automated routines (Haast, Ivanov, & Uludağ, 2018)”, this manuscript should address its lack of field correction and the potential effects on subcortical segmentation.

Line 567: If further analyses are not conducted, need to add other limitations (differences in voxel sizes, sequences, field inhomogeneities, etc.).

Figure 1: Left column (T1-related) images need specific subtitles. 7T “MP2RAGE” – is it T1-weighted (UNI) or T1 map? Optimized 3T: sounds like it’s a “T1w” image, but figure suggests it’s also MP2RAGE.

Figure 3: It would be helpful to see an unsegmented QSM image next to the segmented ones so that readers can visually assess segmentation performance. If space is an issue, perhaps one side half of the brain could be unsegmented and one half could be segmented.

Reviewer #3: This manuscript has not been prepared carefully and many errors and inconsistencies in formatting need to be corrected (see below). The use of vendor-specific acronyms for pulse sequences and parameters in the Methods section is very difficult to follow without a vendor specific manual. Therefore, a full evaluation of differences in the selection of methods and parameter is not possible by the reader but should have been supplied by the authors. The c3T, o3T and 7T methods differ is so many parameters that comparing the results may not address the stated goal of the study. In the Discussion, the following statement illustrates the fundamental weakness of this comparison, “It is important to note that technically it would be possible to match the o3T scan sequence more closely to the 7T sequence. However, the resulting protocol would not meet the criteria for implementation in clinical practice due to SAR and time constraints. It is thus important to note that the improved performance of the 7T protocol cannot be exclusively attributed to differences in field strengths, but also to the constraints imposed by clinical practice.” Greater effort is necessary to adequately prepare comparable acquisition methods on the 3 T and 7 T systems to allow significant conclusion to be drawn. Also, Reference 31 demonstrates the advantage of isotropic resolution available using higher fields, like 7 T, which is a stated in the Conclusion section as a main result.

Keywords should include 7 Tesla

The chosen referencing system (names versus numbers) is not applied consistently.

Error is punctuation, e.g. missing period at the end of the sentence on line 72.

Units should be separated from numerical values (i.e. 3T, 8.2ms), but this format is not followed consistently.

On line 142, the TA units are not correct.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Wen Gu

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Nov 24;15(11):e0236208. doi: 10.1371/journal.pone.0236208.r002

Author response to Decision Letter 0


24 Sep 2020

We would like to thank the reviewers for carefully raising their concerns about our manuscript. We have addressed all of these comments in a pointwise manner in a separately submitted document. The page and line numbers indicated in this rebuttal correspond to the revised manuscript in which changes are reflected in bold for your convenience.

Attachment

Submitted filename: rebuttal.docx

Decision Letter 1

Xi Chen

27 Oct 2020

PONE-D-20-19977R1

3 versus 7 Tesla Magnetic Resonance Imaging for parcellations of subcortical brain structures in clinical settings

PLOS ONE

Dear Dr. Alkemade,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Xi Chen

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: I am largely satisfied with the improvements in the revised manuscript and would like to thank the authors for their efforts. The authors have clarified the methods, results, and figures to a satisfactory degree. While my main critique—regarding the inconsistent acquisition methods being compared—still stands, the authors discuss the issues when relevant and have reoriented the title, abstract, introduction, and discussion to emphasize the clinical relevance of the study.

Specific comments:

Line 97: Two near identical sentences – should remove one.

Line 104: text should be changed from “we could TO run” to “we could NOT run”

Line 157: “19.53 min” should probably be “19:53 min”

Line 566: I disagree with the claim here that these results support isotropic voxels and/or QSM for improved visualization of a surgical target. The current manuscript does not test segmentation of isotropic vs. non-isotropic voxels, nor QSM vs. other modalities. If those control analyses are conducted and agree, then this claim is valid. Otherwise, this sentence should be removed.

Figure 1: Most labels have been added/corrected from the original submission; however, the Optimized 3T T1w image is missing a label (it currently reads as if it is a MP2RAGE, which it is not)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Nov 24;15(11):e0236208. doi: 10.1371/journal.pone.0236208.r004

Author response to Decision Letter 1


27 Oct 2020

Reviewer’s question

Reviewer #2: I am largely satisfied with the improvements in the revised manuscript and would like to thank the authors for their efforts. The authors have clarified the methods, results, and figures to a satisfactory degree. While my main critique—regarding the inconsistent acquisition methods being compared—still stands, the authors discuss the issues when relevant and have reoriented the title, abstract, introduction, and discussion to emphasize the clinical relevance of the study.

Authors’ response

We would like to thank Reviewer #2 once more for meticulously reviewing our manuscript, which has had significant impact on the quality.

Reviewer’s question

Specific comments:

Line 97: Two near identical sentences – should remove one.

Authors’ response

We have now removed the second of these two sentences.

Reviewer’s question

Line 104: text should be changed from “we could TO run” to “we could NOT run”

Authors’ response

We have now made these changes.

Reviewer’s question

Line 157: “19.53 min” should probably be “19:53 min”

Authors’ response

We have replaced 19.53 by 19:53.

Reviewer’s question

Line 566: I disagree with the claim here that these results support isotropic voxels and/or QSM for improved visualization of a surgical target. The current manuscript does not test segmentation of isotropic vs. non-isotropic voxels, nor QSM vs. other modalities. If those control analyses are conducted and agree, then this claim is valid. Otherwise, this sentence should be removed.

Authors’ response

We have now removed the claim about the visualization of a surgical target. The text now reads:

The current study, together with our previous findings, indicate that optimization of 3T MRI scans through the use of isotropic voxels and QSM do indeed allow for more accurate visualization of the STN [34,67].

Reviewer’s question

Figure 1: Most labels have been added/corrected from the original submission; however, the Optimized 3T T1w image is missing a label (it currently reads as if it is a MP2RAGE, which it is not)

Authors’ response

The missing label has now been added.

Decision Letter 2

Xi Chen

9 Nov 2020

3 versus 7 Tesla Magnetic Resonance Imaging for parcellations of subcortical brain structures in clinical settings

PONE-D-20-19977R2

Dear Dr. Alkemade,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Xi Chen

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Xi Chen

13 Nov 2020

PONE-D-20-19977R2

3 versus 7 Tesla Magnetic Resonance Imaging for parcellations of subcortical brain structures in clinical settings

Dear Dr. Alkemade:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xi Chen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    Attachment

    Submitted filename: rebuttal.docx

    Data Availability Statement

    All anonymized data and analysis scripts are available from https://osf.io/4nrku/, under the terms of the Creative Commons Attribution License and complies with the rules of the General Data Protection Regulation (EU) 2016/679.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES